# IPRATROPIUM BROMIDE
> **ANDA215104** · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL · Approved 2022-08-16
## Drug
- **FDA Application Number:** ANDA215104
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** IPRATROPIUM BROMIDE
- **Generic name:** IPRATROPIUM BROMIDE
- **Active ingredients:** IPRATROPIUM BROMIDE
- **Dosage form:** SPRAY, METERED
- **Route:** NASAL
- **Marketing status:** Prescription
- **Sponsor:** AMNEAL
- **Manufacturer:** Amneal Pharmaceuticals NY LLC
- **First approval:** 2022-08-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215104)
---
*AI Analytics · CC0 1.0*